Dr. Reddy's Laboratories Limited — Important, 08-08-2025: General Updates

Dr. Reddy's Laboratories has received the US drug regulator's inspection report for its Miryalaguda API manufacturing facility. The USFDA classified the outcome as 'Voluntary Action Indicated (VAI)', indicating no significant compliance issues requiring enforcement action. This favorable classification means the inspection is officially closed, removing a potential regulatory concern. This development positively impacts the operational clarity of the facility.